Joseph A. Sparano, MD: Multimodal AI Models for Predicting Breast Cancer Recurrence

Joseph A. Sparano, MD, of the Icahn School of Medicine at Mount Sinai, discusses the performance of experimental multimodal AI models integrating clinical, molecular, and histopathologic features to provide prognostic information for early and late recurrence using primary tumor samples and clinical data from participants in the TAILORx trial during the San Antonio Breast Cancer Symposium 2025 (Abstract GS1-08).